Home » Newsletters » BioWorld

BioWorld

June 27, 1994

View Archived Issues

NIH PRICING CLAUSE MAY DISRUPT TECH TRANSFER

OTHER NEWS TO NOTE

SYNERGEN, INDEC CONTINUE WORK ON RHEUMATOID ARTHRITIS

IMRE BEGINS SECOND STAGE PROSORBA TRIAL FOR ARTHRITIS

PHARMACOPEIA COMPLETES SECOND-ROUND FINANCING

CHUGAI LICENSES TARGETECH'S HEPATITIS B TREATMENT

BIOTECH `HEADED FOR SHOOTOUT' OVER HEALTH CARE REFORM PROPOSAL

MICE CARRYING HUMAN CYCLIN GENE DEVELOP BREAST CANCER

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.